Infectious Diseases

216 Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.

215 Association Between Estimated Cumulative Vaccine Antigen Exposure Through the First 23 Months of Life and Non–Vaccine-Targeted Infections From 24 Through 47 Months of Age.

214 Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial.

213 Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study.

212 Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis.

211 Methicillin-resistant Staphylococcus aureus causes sustained collecting lymphatic vessel dysfunction.

210 Shiga Toxin–Producing E. coli Infections Associated with Flour.

209 Integrated genomic and interfacility patient-transfer data reveal the transmission pathways of multidrug-resistant Klebsiella pneumoniae in a regional outbreak.

208 Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management.

207 Phase 2 Placebo-Controlled Trial of Two Vaccines to Prevent Ebola in Liberia.

206 Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors.

205 Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine.

204 Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques.

203 Increased adaptive immune responses and proper feedback regulation protect against clinical dengue.

202 A randomized synbiotic trial to prevent sepsis among infants in rural India.

201 Effect of acute Zika virus infection on sperm and virus clearance in body fluids: a prospective observational study.

200 Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.

199 A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis.

198 Efficacy of Recombinant Influenza Vaccine in Adults 50 Years of Age or Older.

197 A point-of-care microfluidic biochip for quantification of CD64 expression from whole blood for sepsis stratification.

Free Images for Presentation: sunipix SUNIPIX